This post hoc analysis in a highly selected sample of IST-3 supports the rationale of A Study of the Efficacy and Safety of Activase ( Alteplase ) in Patients With Mild Stroke ( PRISMS ) trial-a randomized , phase IIIb study to evaluate IV r-tPA in mild ischemic stroke .